Publications by authors named "Martin Satny"

Claim this Profile
G
Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemia.
Martin Satny, Veronika Todorovova, Tereza Altschmiedova, Jaroslav A Hubacek, Lucie Dlouha

J Clin Lipidol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk in myositis patients compared with the general population.
Sabina Oreska, Hana Storkanova, Aneta Pekacova, Jaroslav Kudlicka, Vladimir Tuka, Martin Satny

Rheumatology (Oxford)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Dyslipidemia - the known unknown].
Martin Šatný

Vnitr Lek· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The frequency of, and predisposing risk factors for, ciprofloxacin-induced neuro-psychiatric adverse drug reactions.
Jan Miroslav Hartinger, Eliska Dvorackova, Marek Myslivecek, Zdenka Hruskova, Martin Satny

Bratisl Lek Listy· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias.
Michal Vrablík, Ivana Šarkanová, Katarína Breciková, Petra Šedová, Martin Šatný

PLoS One· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology.
Tereza Altschmiedová, Veronika Todorovová, Michaela Šnejdrlová, Martin Šatný, Richard Češka

Curr Atheroscler Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study.
Sabina Oreska, Hana Storkanova, Jaroslav Kudlicka, Vladimir Tuka, Ondrej Mikes, Martin Satny

Front Med (Lausanne)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins and Inflammation.
Martin Satny, Jaroslav A Hubacek, Michal Vrablik

Curr Atheroscler Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Fixed-dose combination of rosuvastatin and ezetimibe].
Martin Šatný

Vnitr Lek· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics of Familial Hypercholesterolemia: New Insights.
Michal Vrablik, Lukas Tichý, Tomas Freiberger, Vladimir Blaha, Martin Satny

Front Genet· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Gene Score for Predicting Hypertriglyceridemia: New Insights from a Czech Case-Control Study.
Jaroslav A Hubacek, Dana Dlouha, Vera Adamkova, Lucie Schwarzova, Vera Lanska, Martin Satny

Mol Diagn Ther· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.
Michal Vrablik, Katarina Raslová, Branislav Vohnout, Vladimir Blaha, Martin Satny

Atherosclerosis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis